↓ Skip to main content

Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis

Overview of attention for article published in Frontiers in Medicine, June 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis
Published in
Frontiers in Medicine, June 2020
DOI 10.3389/fmed.2020.00288
Pubmed ID
Authors

Kalliopi Klavdianou, Argyro Lazarini, Alexandros Grivas, Dimitrios Tseronis, Christina Tsalapaki, Panagiota Rapsomaniki, Katerina Antonatou, Konstantinos Thomas, Dimitrios Boumpas, Pelagia Katsimbri, Dimitrios Vassilopoulos

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 15%
Student > Doctoral Student 5 13%
Student > Ph. D. Student 3 8%
Student > Bachelor 3 8%
Professor 2 5%
Other 8 21%
Unknown 12 31%
Readers by discipline Count As %
Medicine and Dentistry 13 33%
Pharmacology, Toxicology and Pharmaceutical Science 5 13%
Nursing and Health Professions 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Unspecified 1 3%
Other 2 5%
Unknown 13 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2020.
All research outputs
#12,864,909
of 23,215,490 outputs
Outputs from Frontiers in Medicine
#1,870
of 5,928 outputs
Outputs of similar age
#178,606
of 399,265 outputs
Outputs of similar age from Frontiers in Medicine
#69
of 170 outputs
Altmetric has tracked 23,215,490 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,928 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,265 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 170 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.